表紙
市場調査レポート

体外診断市場(〜2018年):競合情勢を形成する整理統合・分散化・遺伝子検査の需要

In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape

発行 GBI Research 商品コード 235100
出版日 ページ情報 英文 136 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
体外診断市場(〜2018年):競合情勢を形成する整理統合・分散化・遺伝子検査の需要 In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape
出版日: 2012年03月23日 ページ情報: 英文 136 Pages
担当者のコメント
市場規模の数値が主要国別・セグメント別に分析された、体外診断市場レポートとしては珍しいレポートです
概要

世界の体外診断(IVD)市場は、2011年から2018年の期間中CAGR6.8%で拡大し、2018年までに723億米ドルに達すると予測されています。免疫化学市場が、市場分類の中で最大のシェアを占め、2011年から2018年の間にCAGR6.8%で拡大し、2018年までに255億米ドルに達すると見られています。

当レポートでは、世界の主要国における体外診断市場について調査し、体外診断の7つの市場分類別による市場規模データ、年間の市場収益データ、2018年までの7ヵ年予測、2010年の企業シェアデータ、主要市場動向の定性分析、および各市場分類における市場影響因子の定性分析を提供しており、主要企業のプロファイル、競合情勢および主要技術の分析とともに、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 世界の体外診断市場:市場特徴

  • 市場収益:2004年〜2011年
  • 市場収益:2011年〜2018年
  • 主要企業の市場シェア:2010年
  • 主な市場動向
  • 市場力学

第4章 世界の体外診断市場:カテゴリー分析・予測

  • カテゴリー全体の分析
  • 免疫化学
  • 免疫化学市場:市場力学
  • 臨床化学
  • 臨床化学市場:市場力学
  • 感染免疫学
  • 感染免疫学市場:市場力学
  • 血液学
  • 血液学市場微生物培養
  • 微生物培養
  • 微生物培養微生物培養
  • 組織学・細胞学
  • 組織学・細胞学市場:市場力学
  • 遺伝子検査
  • 遺伝子検査市場:市場力学

第5章 世界の体外診断市場:各国分析・予測

  • 全体の分析
  • 過去の収益実績・予測:国別

第6章 世界の体外診断市場:競合評価

  • 主な市場参入企業

第7章 世界の体外診断市場:製品パイプライン分析

  • パイプライン製品のサマリー
  • 主なパイプライン製品のプロファイル

第8章 世界の体外診断市場:整理統合情勢

  • 取引数:2008年〜2011年
  • 主要取引:2008年〜2011年

第9章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GBIME0067MR

GBI Research's report, "In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape" provides key data, information and analysis on the global In Vitro Diagnostics (IVD) market. The report provides market landscape, competitive landscape and market trends information on seven IVD market categories: immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, with analysis of the major Mergers and Acquisitions (M&A) in the last four years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • The key geographies include, the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Market size data for seven In Vitro Diagnostics market categories - immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing.
  • Annualized market revenue data, seven-year forecasts through to 2018, as well as company share data for 2010.
  • Qualitative analysis of key market trends for the In Vitro Diagnostics market.
  • Qualitative analysis of market drivers and restraints in each category within the In Vitro Diagnostics market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading technologies in the market

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the In Vitro Diagnostics market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify the players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.
  • What's the next big thing in the the In Vitro Diagnostics market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global In Vitro Diagnostics market and the factors shaping it.

Abstract

In Vitro Diagnostics Market Forecast to Increase at a CAGR of 6.8% during 2011-2018

The global In Vitro Diagnostics (IVD) market is forecast to grow at a Compounded Annual Growth Rate (CAGR) of 6.8% during 2011-2018 to reach a value of $72.3 billion by 2018. The IVD market will be driven by the shift to preventive healthcare from curative healthcare, the increase in the incidence of infectious diseases, the increase in the percentage of elderly people and technological advances.

Technological advances such as automation, biosensor technology, miniaturization, integration of workstations, and Information Technology (IT) optimizing laboratory workflow will lead to an increased demand for innovative technologies and drive the growth of the overall IVD market.

Emerging countries have huge potential for IVD and demand will be high in these countries.

Factors such as an increase in income levels, growing awareness among patients, an increase in the patient pool and the increased adoption of Point of Care (POC) testing will drive the market growth in these countries. The advantages of POC testing include reduced Turnaround Time (TAT), minimal infrastructure requirements and accessibility. These advantages will be major factors contributing to the increased demand for POC tests and will drive the growth of the overall IVD market.

The Immunochemistry Category is expected to be the Largest Revenue Generator

The immunochemistry market is expected to grow at a CAGR of 6.8% during 2011-2018. It will be the largest revenue generator in the IVD market with an expected value of $25.5 billion by 2018. Many factors, such as the increasing incidence of infectious diseases, the fast Turn Around Time (TAT) of these tests and the introduction of innovative tests, will drive the market growth.

Companies are focusing on introducing new tests to meet the growing demand for immunochemistry testing across the world. The immunochemistry market has the highest number of pipeline products in the IVD market. There are a total of 1,726 pipeline products, which accounts for 59% of the total pipeline products in the IVD market.

The increasing prevalence of infectious diseases and cardiac disorders and the increasing elderly population is driving the demand for immunochemistry tests. Physicians are opting for immunochemistry products over other traditional tests due to the short TAT and high specificity of the tests. This has resulted in an increased usage of immunoassays for the diagnosis of various diseases such as infectious diseases, oncology and other disorders. In order to leverage this, the companies are focusing on developing advanced immunochemistry products.

Demand for Decentralized Laboratory Testing is Increasing Significantly Worldwide

The healthcare delivery system has undergone a transition from hospital delivery to POC. Decentralized laboratory testing is another term for near-patient testing or POC testing. It involves clinical testing of biological samples at or near the location of patient care. Many factors have contributed to this shift from central laboratory testing to POC testing. In POC testing the TAT is short as results are rapid and treatment starts without any delay, the time of sample transfer to central labs and then report generation and transfer steps are eliminated.

Technological advances have also enabled POC testing to be more effective. The integration of IT with POC testing devices has improved data management and connectivity. The connectivity has enabled real time information exchange between patients and physicians leading to on time treatment. This subsequently leads to improved patient satisfaction, which drives the demand for POC testing.

Accessibility is another major factor that plays a role in patients preferring POC testing. These tests need minimal infrastructural requirements and can be performed in settings such as physicians' offices, emergency rooms, intensive care units and patients' homes.

The demand for POC testing is growing significantly in emerging countries as there are a limited number of hospitals and central laboratories and the need for healthcare is constantly increasing. These factors are leading to overcrowded hospitals and long waiting times, which cause delays to treatment and patient dissatisfaction. POC testing is the preferred option to meet the growing needs of patients in countries with poor healthcare infrastructure, as POC tests can be conducted in any setting and minimize the need for proper infrastructure.

All of these factors have led to the decentralization of laboratories worldwide.

Genetic Testing will See a High Adoption Rate Worldwide

The genetic testing market is expected to grow at a CAGR of 10.3% to reach a value of $1.9 billion by 2018. Many factors, such as direct to consumer genetic testing, growing interest in personalized medicine and an increase in the application of genetic testing in the diagnosis of infectious diseases will drive the adoption rate of genetic tests in the near future. The direct to customer genetic testing is driving the growth of the genetic testing market. The demand has increased because of improved accessibility and convenience to customers. The involvement of doctors and insurance agencies is also eliminated, which further increases the convenience for patients.

The growing interest in personalized medicine is driving the genetic testing market across the world. Personalized medicine involves the practice of using genetic information to decide about medical care for an individual. Various pharmacogenomic tests are used for the prognosis and diagnosis of diseases. The increasing application of genetic testing for the diagnosis of infectious diseases is driving the overall market growth. Most laboratories are now using genetic tests for the diagnosis of infectious disease, especially for Sexually Transmitted Diseases (STDs) such as Acquired Immuno Deficiency Syndrome/ Human immunodeficiency virus (AIDS/HIV). Apart from STDs, companies are now focusing on developing a rapid test for the detection of respiratory diseases.

These factors will drive the adoption rate of genetic testing worldwide.

F. Hoffmann-La Roche Ltd. and Siemens Healthcare were the Leading Companies in the Global in Vitro Diagnostics Market in 2010

F. Hoffmann-La Roche Ltd. and Siemens Healthcare were the leading companies in the global IVD market in 2010, each with a market share of 11%. The IVD market is fragmented and large numbers of smaller companies are operating in this market. The wide product portfolio of F. Hoffmann-La Roche Ltd. helped it gain an 11% market share in the IVD market. The company has acquired mtm Laboratories, which has expanded its tissue diagnostics products portfolio. Siemens' acquisition of Bayer's diagnostic portfolio helped it to become a key company in the IVD market with an 11% share.

These two companies are closely followed by Abbott with a 10% market share. Abbott offers a broad range of innovative IVD systems and tests for hospitals, reference labs, blood banks, physicians' offices and clinics. Abbott is a strong company in the POC testing market and has a wide product portfolio of rapid tests and POC.

Emerging Countries Will be the Key Focus Areas for IVD Companies

Emerging countries such as India, China and Brazil hold good potential for IVD companies. Pricing pressures in developed countries and increased healthcare spending in emerging countries are the factors why IVD companies are expanding their presence in emerging markets. Other favorable factors for IVD companies include the huge untapped market, the demand for rapid tests and POC testing, increased awareness among patients, the increase in government initiatives to provide better healthcare facilities, the increasing elderly population and the increasing incidence of various diseases. All of these factors have resulted in an increase in demand for IVD.

The lack of proper infrastructure will propel the growth of POC testing in these markets. POC tests are portable, easy to use and do not require any expertise or infrastructure. The growing incidence of diseases such as diabetes, obesity, cardiac disorders and other chronic conditions are major factors driving the demand for POC testing.

Government initiatives investing in the healthcare sector are also driving the IVD demand in these countries. Due to the increase in the healthcare budget, there has been an increase in the number of hospitals and primary care centers. This increase has subsequently led to an increased demand for IVD. In China, the demand for IVD is increasing due to increased government healthcare spending, the increased elderly population, the untapped market and the replacement of obsolete IVD devices. Due to the low penetration rate there is a huge untapped market in China. On average, only 50% of the hospitals in China have biochemistry analyzers. This presents a good opportunity for IVD devices in China.

With an increase in demand for IVD devices, reagents will also experience a similar rise in demand as they are complementary products. In India, the increase in disposable income, the increase in the patient pool, the growing elderly population and the increasing rate of obesity are expected to drive the IVD market. Obesity and old age are the major risk factors for chronic diseases. The chronic diseases require frequent testing, which will drive the growth of the IVD market.

The penetration into rural parts of India is also increasing. This includes diagnostic private chains such as SRL Ranbaxy, which have high workflow and also attract business from hospitals in the US and UK that outsource their pathology demands.

The factors presented above demonstrate the favorable market opportunities for IVD companies in emerging countries. Companies such as Abbott, Roche and Siemens and smaller companies, such as BioMerieux, Transasia, Becton Dickenson, Beckman Coulter, Johnson & Johnson (J&J) and Sysmex, are expanding their presence in emerging countries such as India, China, Brazil and Russia.

The US was the Largest Market for the IVD Industry in 2011

The US was the largest market for IVD and accounted for 50% of the global IVD market in 2011. The IVD market was valued at $19.4 billion in 2011 and is forecast to grow at a CAGR of 6.6% to reach $30.3 billion by 2018. In the US, the genetic testing category is the fastest growing category and is expected to increase at a CAGR of 11.3% to reach $1.1 billion by 2018. The market is expected to be driven by the increasing adoption of genetic testing by physicians. The completion of a human genome project has also increased the application areas for genetic testing.

The shift to preventive healthcare will drive the demand for IVD. Technological advances leading to short TAT, improved specificity and accuracy, automation, and the introduction of innovative POC testing will drive the market growth.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GBI Research Guidance

3. Global In Vitro Diagnostics Market: Market Characterization

  • 3.1. Global in Vitro Diagnostics Market, Revenue ($bn), 2004-2011
  • 3.2. Global In Vitro Diagnostics Market, Revenue ($bn), 2011-2018
  • 3.3. Global In Vitro Diagnostics Market, Key Company Shares (%), 2010
  • 3.4. Global In Vitro Diagnostics Market: Key Market Trends
    • 3.4.1. Growing Trend towards Preventive Healthcare is Driving the Growth of In Vitro Diagnostics
    • 3.4.2. Increased Use of Information Technology in IVD for Effective Workflow Management
    • 3.4.3. Laboratory Consolidation is a Major Trend in the IVD Industry
    • 3.4.4. Demand for Decentralized Laboratory Testing is increasing Significantly Across the World
    • 3.4.5. Consolidation Activity has Increased Significantly in the IVD Industry in Recent Years
    • 3.4.6. Automation is the Key Technology Trend in IVD Market
  • 3.5. Global In Vitro Diagnostics Market: Market Dynamics
    • 3.5.1. Market Drivers
    • 3.5.2. Market Restraints

4. Global In Vitro Diagnostics Market: Market Category Analysis and Forecasts

  • 4.1. In Vitro Diagnostics Market: Cross-Category Analysis
  • 4.2. Immunochemistry
    • 4.2.1. Immunochemistry Market, Global, Revenue ($m), 2004-2011
    • 4.2.2. Immunochemistry Market, Global, Revenue ($m), 2011-2018
    • 4.2.3. Immunochemistry Market, Global, Company Share, (%), 2010
  • 4.3. Immunochemistry Market: Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
  • 4.4. Clinical Chemistry
    • 4.4.1. Clinical Chemistry Market, Global, Revenue ($m), 2004-2011
    • 4.4.2. Clinical Chemistry Market, Global, Revenue ($m), 2011-2018
    • 4.4.3. Clinical Chemistry Market, Global, Key Company Shares, (%), 2010
  • 4.5. Clinical Chemistry Market: Market Dynamics
    • 4.5.1. Market Drivers
    • 4.5.2. Market Restraints
  • 4.6. Infectious Immunology
    • 4.6.1. Infectious Immunology Market, Global, Revenue ($m), 2004-2011
    • 4.6.2. Infectious Immunology Market, Global, Revenue ($m), 2011-2018
    • 4.6.3. Infectious Immunology Market, Global, Key Company Shares, (%), 2010
  • 4.7. Infectious Immunology Market: Market Dynamics
    • 4.7.1. Market Drivers
    • 4.7.2. Market Restraints
  • 4.8. Hematology
    • 4.8.1. Hematology Market, Global, Revenue ($m), 2004-2011
    • 4.8.2. Hematology Market, Global, Revenue ($m), 2011-2018
    • 4.8.3. Hematology Market, Global, Key Company Shares, (%), 2010
  • 4.9. Hematology Market: Market Dynamics
    • 4.9.1. Market Drivers
    • 4.9.2. Market Restraints
  • 4.10. Microbiology Culture
    • 4.10.1. Microbiology Culture Market, Global, Revenue ($m), 2004-2011
    • 4.10.2. Microbiology Culture Market, Global, Revenue ($m), 2011-2018
    • 4.10.3. Microbiology Culture Market, Global, Company Shares, (%), 2010
  • 4.11. Microbiology Culture Market: Market Dynamics
    • 4.11.1. Market Drivers
    • 4.11.2. Market Restraints
  • 4.12. Histology and Cytology
    • 4.12.1. Histology and Cytology Market, Global, Revenue ($m), 2004-2011
    • 4.12.2. Histology and Cytology Market, Global, Revenue ($m), 2011-2018
    • 4.12.3. Histology and Cytology Market, Global, Company Share, (%), 2010
  • 4.13. Histology and Cytology Market: Market Dynamics
    • 4.13.1. Market Drivers
    • 4.13.2. Market Restraints
  • 4.14. Genetic Testing
    • 4.14.1. Genetic Testing Market, Global, Revenue ($m), 2004-2011
    • 4.14.2. Genetic Testing Market, Global, Revenue ($m), 2011-2018
    • 4.14.3. Genetic Testing Market, Global, Company Share, (%), 2010
  • 4.15. Genetic Testing Market: Market Dynamics
    • 4.15.1. Market Drivers
    • 4.15.2. Market Restraints

5. Global In Vitro Diagnostics Market: Country Analysis and Forecasts

  • 5.1. In Vitro Diagnostics Market: Cross-Country Analysis
  • 5.2. Historic and Forecast Revenue, By Country
    • 5.2.1. In Vitro Diagnostics Market, The US, Revenue ($m), 2004-2011
    • 5.2.2. In Vitro Diagnostics Market, the US, Revenue ($m), 2011-2018
    • 5.2.3. In Vitro Diagnostics Market, Canada, Revenue ($m), 2004-2011.
    • 5.2.4. In Vitro Diagnostics Market, Canada, Revenue ($m), 2011-2018
    • 5.2.5. In Vitro Diagnostics Market, the UK, Revenue ($m), 2004-2011
    • 5.2.6. In Vitro Diagnostics Market, the UK, Revenue ($m), 2011-2018
    • 5.2.7. In Vitro Diagnostics Market, Germany, Revenue ($m), 2004-2011
    • 5.2.8. In Vitro Diagnostics Market, Germany, Revenue ($m), 2011-2018
    • 5.2.9. In Vitro Diagnostics Market, France, Revenue ($m), 2004-2011
    • 5.2.10. In Vitro Diagnostics Market, France, Revenue ($m), 2011-2018
    • 5.2.11. In Vitro Diagnostics Market, Italy, Revenue ($m), 2004-2011
    • 5.2.12. In Vitro Diagnostics Market, Italy, Revenue ($m), 2011-2018
    • 5.2.13. In Vitro Diagnostics Market, Spain, Revenue ($m), 2004-2011
    • 5.2.14. In Vitro Diagnostics Market, Spain, Revenue ($m), 2011-2018
    • 5.2.15. In Vitro Diagnostics Market, Japan, Revenue ($m), 2004-2011
    • 5.2.16. In Vitro Diagnostics Market, Japan, Revenue ($m), 2011-2018
    • 5.2.17. In Vitro Diagnostics Market, China, Revenue ($m), 2004-2011
    • 5.2.18. In Vitro Diagnostics Market, China, Revenue ($m), 2011-2018
    • 5.2.19. In Vitro Diagnostics Market, India, Revenue ($m), 2004-2011
    • 5.2.20. In Vitro Diagnostics Market, India, Revenue ($m), 2011-2018
    • 5.2.21. In Vitro Diagnostics Market, Australia, Revenue ($m), 2004-2011
    • 5.2.22. In Vitro Diagnostics Market, Australia, Revenue ($m), 2011-2018
    • 5.2.23. In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004-2011
    • 5.2.24. In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011-2018

6. Global In Vitro Diagnostics Market: Competitive Assessment

  • 6.1. Key Market Participants
    • 6.1.1. F. Hoffmann-La Roche Ltd.
    • 6.1.2. Siemens Healthcare (Subsidiary of Siemens AG)
    • 6.1.3. Abbott Laboratories
    • 6.1.4. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
    • 6.1.5. Ortho-Clinical Diagnostics Inc. (Subsidiary of Johnson & Johnson)
    • 6.1.6. bioMerieux S.A. (Subsidiary of Merieux Alliance group)
    • 6.1.7. Sysmex Corporation (Sysmex)
    • 6.1.8. Becton, Dickinson and Company
    • 6.1.9. Bio-Rad Laboratories, Inc. (Bio-Rad)
    • 6.1.10. Alere Inc. (formerly Inverness Medical Innovations, Inc.)

7. Global In Vitro Diagnostics Market: Product Pipeline Analysis

  • 7.1. In Vitro Diagnostics Market: Pipeline Products Summary
    • 7.1.1. Pipeline Products Analysis: Immunochemistry Market
    • 7.1.2. Pipeline Products Analysis: Infectious Immunology
    • 7.1.3. Pipeline Products Analysis: Genetic Testing
    • 7.1.4. Pipeline Products Analysis: Clinical Chemistry
    • 7.1.5. Pipeline Products Analysis: Hematology
    • 7.1.6. Pipeline Products Analysis: Microbiology Culture
    • 7.1.7. Pipeline Products Analysis: Histology and Cytology
  • 7.2. In Vitro Diagnostics Market: Profiles of Key Pipeline Products
    • 7.2.1. ImmProCon Technology
    • 7.2.2. RAPIDPoint 500 System - Lactate Assay
    • 7.2.3. Sali - Chek Reader
    • 7.2.4. Point-of-Care Diagnostic Device
    • 7.2.5. ACE Alera Clinical Chemistry System - Direct A1c Assay
    • 7.2.6. Advia 120 Hematology System - IRF Test
    • 7.2.7. Advia 2120 Hematology System - MPC Test
    • 7.2.8. AIA-600 II - D-dimer Test

8. Global In Vitro Diagnostics Market: Consolidation Landscape

  • 8.1. Deals by Number, 2008-2011
  • 8.2. In Vitro Diagnostics Market: Key Deals, 2008-2011
    • 8.2.1. Roche Completes Acquisition of mtm laboratories
    • 8.2.2. bioMerieux Acquires Argene
    • 8.2.3. Thermo Fisher Completes Acquisition of Phadia
    • 8.2.4. Quest Diagnostics Completes Acquisition of Athena Diagnostics
    • 8.2.5. Danaher Completes Acquisition of Beckman Coulter
    • 8.2.6. Laboratory Corporation of America Completes Acquisition of Genzyme Genetics From Genzyme
    • 8.2.7. Merck Completes Acquisition of Millipore
    • 8.2.8. Thermo Fisher Scientific Completes Acquisition of Ahura Scientific
    • 8.2.9. Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics
    • 8.2.10. Quidel Completes Acquisition of Diagnostic HYBRIDS
    • 8.2.11. Danaher Completes Acquisition of Genetix Group
    • 8.2.12. QIAGEN Completes Acquisition of DxS
    • 8.2.13. Thermo Fisher Scientific Completes Acquisition of B.R.A.H.M.S.
    • 8.2.14. Laboratory Corporation of America Holdings Completes Acquisition of Monogram Biosciences
    • 8.2.15. Inverness Medical Innovations Completes Acquisition of Concateno From Marwyn
    • 8.2.16. Gen-Probe Acquires Tepnel Life Sciences
    • 8.2.17. Hologic Acquires Third Wave Technologies
    • 8.2.18. Immucor Acquires BioArray Solutions
    • 8.2.19. Werfen Life Acquires INOVA Diagnostics
    • 8.2.20. Abbott Laboratories Acquires Ibis Biosciences from Isis Pharmaceuticals
    • 8.2.21. bioMerieux Acquires AviaraDx
    • 8.2.22. Bio-Rad Laboratories Acquires Diamed

9. Appendix

  • 9.1. Definitions
    • 9.1.1. Clinical Chemistry
    • 9.1.2. Immunochemistry Test Reagents
    • 9.1.3. Hematology
    • 9.1.4. Histology And Cytology
    • 9.1.5. Microbiology Culture
    • 9.1.6. Infectious Immunology
    • 9.1.7. Genetic Testing
  • 9.2. Sources
  • 9.3. Acronyms
  • 9.4. Research Methodology
    • 9.4.1. Secondary Research
    • 9.4.2. Primary Research
    • 9.4.3. Models
    • 9.4.4. Forecasts
    • 9.4.5. Expert Panels
  • 9.5. Contact Us
  • 9.6. Disclaimer

List of Tables

  • Table 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004-2011
  • Table 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011-2018
  • Table 3: Global In Vitro Diagnostics Market, Key Company, Revenue ($m) 2010
  • Table 4: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2007
  • Table 5: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2008-2009
  • Table 6: Key M&A, IVD Market, Global, 2010-2011
  • Table 7: In Vitro Diagnostics Market, Global, Cross Category Analysis ,CAGR (%), 2004-2018
  • Table 8: Immunochemistry Market, Global, Revenue ($m), 2004-2011
  • Table 9: Immunochemistry Market, Global, Revenue ($m), 2011-2018
  • Table 10: Global Immunochemistry Market, Key Company, Revenue ($m) 2010
  • Table 11: Global Immunochemistry Market, Tumor Markers
  • Table 12: Clinical Chemistry Market, Global, Revenue ($m), 2004-2011
  • Table 13: Clinical Chemistry Market, Global, Revenue ($m), 2011-2018
  • Table 14: Clinical Chemistry Market, Global, Key Company Revenue ($m), 2010
  • Table 15: Infectious Immunology Market, Global, Revenue ($m), 2004-2011
  • Table 16: Infectious Immunology Market, Global, Revenue ($m), 2011-2018
  • Table 17: Infectious Immunology Market, Global, Key Company, Revenue ($m) 2010
  • Table 18: Hematology Market, Global, Revenue ($m), 2004-2011
  • Table 19: Hematology Market, Global, Revenue ($m), 2011-2018
  • Table 20: Hematology Market, Global, Key Company Revenue ($m), 2010
  • Table 21: Microbiology Culture Market, Global, Revenue ($m), 2004-2011
  • Table 22: Microbiology Culture Market, Global, Revenue ($m), 2011-2018
  • Table 23: Microbiology Culture Market, Global, Key Company Revenue ($m), 2010
  • Table 24: Histology and Cytology Market, Global, Revenue ($m), 2004-2011
  • Table 25: Histology and Cytology Market, Global, Revenue ($m), 2011-2018
  • Table 26: Histology and Cytology Market, Global, Key Company, Revenue ($m) 2010
  • Table 27: Genetic Testing Market, Global, Revenue ($m), 2004-2011
  • Table 28: Genetic Testing Market, Global, Revenue ($m), 2011-2018
  • Table 29: Genetic Testing Market, Global, Key Company Revenue ($m), 2010
  • Table 30: In Vitro Diagnostics Market, Global, Genetic Testing, Home Genetic Test Kits, Examples
  • Table 31: IVD Market, Global, Cross-Country Analysis, CAGR (%), 2004-2018
  • Table 32: In Vitro Diagnostics Market, The US, Revenue ($m), 2004-2011
  • Table 33: In Vitro Diagnostics Market, The US, Revenue ($m), 2011-2018
  • Table 34: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004-2011
  • Table 35: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Table 36: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004-2011
  • Table 37: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Table 38: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004-2011
  • Table 39: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011-2018
  • Table 40: In Vitro Diagnostics Market, France, Revenue ($m), 2004-2011
  • Table 41: In Vitro Diagnostics Market, France, Revenue ($m), 2011-2018
  • Table 42: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004-2011
  • Table 43: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Table 44: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004-2011
  • Table 45: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Table 46: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004-2011
  • Table 47: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Table 48: In Vitro Diagnostics Market, China, Revenue ($m), 2004-2011
  • Table 49: In Vitro Diagnostics Market, China, Revenue ($m), 2011-2018
  • Table 50: In Vitro Diagnostics Market, India, Revenue ($m), 2004-2011
  • Table 51: In Vitro Diagnostics Market, India, Revenue ($m), 2011-2018
  • Table 52: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004-2011
  • Table 53: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011-2018
  • Table 54: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004-2011
  • Table 55: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011-2018
  • Table 56: In Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2011
  • Table 57: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage
  • Table 58: Immunochemistry Market, Global, Pipeline Products Analysis, 2011
  • Table 59: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011
  • Table 60: Genetic Testing Market, Global, Pipeline Products Analysis, 2011
  • Table 61: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011
  • Table 62: Hematology Market, Global, Pipeline Products Analysis, 2011
  • Table 63: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011
  • Table 64: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011
  • Table 65: ImmProCon Technology, Product Status, 2011
  • Table 66: RAPIDPoint 500 System, Product Status, 2011
  • Table 67: Sali - Chek Reader, Product Status, 2011
  • Table 68: Point-of-Care Diagnostic Device, Product Status, 2011
  • Table 69: ACE Alera Clinical Chemistry System - Direct A1c Assay, Product Status, 2011
  • Table 70: Advia 120 Hematology System - IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011
  • Table 71: Advia 2120 Hematology System - MPC (Mean Platelet Component) Test, Product Status, 2011
  • Table 72: AIA (Automated Immunoassay Analyzer)-600 II - D-dimer Test, Product Status, 2011
  • Table 73: IVD Market, Mergers and Acquisitions, Number of Deals, Global, 2008-2011
  • Table 74: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2008
  • Table 75: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 - Table 1
  • Table 76: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 - Table 2
  • Table 77: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 - Table 1
  • Table 78: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 - Table 2
  • Table 79: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 - Table 1
  • Table 80: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 - Table 2

List of Figures

  • Figure 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004-2011
  • Figure 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011-2018
  • Figure 3: Global In Vitro Diagnostics Market, Key Company Shares (%), 2010
  • Figure 4: In Vitro Diagnostics Market, Global, Cross-Category Analysis , CAGR (%), 2004-2018
  • Figure 5: Immunochemistry Market, Global, Revenue ($m), 2004-2011
  • Figure 6: Immunochemistry Market, Global, Revenue ($m), 2011-2018
  • Figure 7: Immunochemistry Market, Global, Company Share, (%), 2010
  • Figure 8: Clinical Chemistry Rapid Tests & POC Market, Global, Revenue ($m), 2004-2011
  • Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2011-2018
  • Figure 10: Clinical Chemistry Market, Global, Key Company, Revenues ($m) 2010
  • Figure 11: Infectious Immunology Market, Global, Revenue ($m), 2004-2011
  • Figure 12: Infectious Immunology Market, Global, Revenue ($m), 2011-2018
  • Figure 13: Infectious Immunology Market, Global, Key Company Shares, (%), 2010
  • Figure 14: Hematology Market, Global, Revenue ($m), 2004-2011
  • Figure 15: Hematology Market, Global, Revenue ($m), 2011-2018
  • Figure 16: Hematology Market, Global, Key Company Shares, (%), 2010
  • Figure 17: Microbiology Culture Market, Global, Revenue ($m), 2004-2011
  • Figure 18: Microbiology Culture Market, Global, Revenue ($m), 2011-2018
  • Figure 19: Microbiology Culture Market, Global, Company Shares, (%), 2010
  • Figure 20: Histology and Cytology Market, Global, Revenue ($m), 2004-2011
  • Figure 21: Histology and Cytology Market, Global, Revenue ($m), 2011-2018
  • Figure 22: Histology and Cytology Market, Global, Company Share, (%), 2010
  • Figure 23: Genetic Testing Market, Global, Revenue ($m), 2004-2011
  • Figure 24: Genetic Testing Market, Global, Revenue ($m), 2011-2018
  • Figure 25: Genetic Testing Market, Global, Company Share, (%), 2010
  • Figure 26: In Vitro Diagnostics Market, Global, Cross-Country Analysis, CAGR (%), 2004-2018
  • Figure 27: In Vitro Diagnostics Market, The US, Revenue ($m), 2004-2011
  • Figure 28: In Vitro Diagnostics Market, the US, Revenue ($m), 2011-2018
  • Figure 29: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004-2011
  • Figure 30: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011-2018
  • Figure 31: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004-2011
  • Figure 32: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011-2018
  • Figure 33: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004-2011
  • Figure 34: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011-2018
  • Figure 35: In Vitro Diagnostics Market, France, Revenue ($m), 2004-2011
  • Figure 36: In Vitro Diagnostics Market, France, Revenue ($m), 2011-2018
  • Figure 37: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004-2011
  • Figure 38: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011-2018
  • Figure 39: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004-2011
  • Figure 40: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011-2018
  • Figure 41: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004-2011
  • Figure 42: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011-2018
  • Figure 43: In Vitro Diagnostics Market, China, Revenue ($m), 2004-2011
  • Figure 44: In Vitro Diagnostics Market, China, Revenue ($m), 2011-2018
  • Figure 45: In Vitro Diagnostics Market, India, Revenue ($m), 2004-2011
  • Figure 46: In Vitro Diagnostics Market, India, Revenue ($m), 2011-2018
  • Figure 47: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004-2011
  • Figure 48: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011-2018
  • Figure 49: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004-2011
  • Figure 50: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011-2018
  • Figure 51: In Vitro Diagnostics Market, Global, Competitive Assessment
  • Figure 52: In Vitro Diagnostics Market, Global, Pipeline Product Summary (%), 2010
  • Figure 53: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage
  • Figure 54: Immunochemistry Market, Global, Pipeline Products Analysis, 2011
  • Figure 55: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011
  • Figure 56: Genetic Testing Market, Global, Pipeline Products Analysis, 2011
  • Figure 57: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011
  • Figure 58: Hematology Market, Global, Pipeline Products Analysis, 2011
  • Figure 59: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011
  • Figure 60: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011
  • Figure 61: Cardiovascular Devices Market, Mergers and Acquisitions, Number of Deals, Global, 2008-2011
Back to Top